110
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Cross-Cultural Adaptation and Reliability Testing of Chinese Version of the Living with Medicines Questionnaire in Elderly Patients with Chronic Diseases

ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 2477-2487 | Published online: 17 Dec 2020

References

  • Bennett JE, Stevens GA, Mathers CD, et al. NCD countdown 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet. 2018;392(10152):1072–1088. doi:10.1016/S0140-6736(18)31992-5
  • World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. World Health Organization; 2009.
  • Chun L.Re-partitioning population age group and its implications. Popul Res. 2017;41(5):16–25.
  • Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013;35:75–83.
  • Islam MM, Valderas JM, Yen L, et al. Multimorbidity and comorbidity of chronic diseases among the senior Australians: prevalence and patterns. PLoS One. 2014;9(1):e83783. doi:10.1371/journal.pone.0083783
  • Wang SB, D’Arcy C, Yu YQ, et al. Prevalence and patterns of multimorbidity in northeastern China: a cross-sectional study. Public Health. 2015;129(11):1539–1546. doi:10.1016/j.puhe.2015.06.013
  • Zhao Y, Atun R, Oldenburg B, et al. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data. Lancet Glob Health. 2020;8(6):e840–e849. doi:10.1016/S2214-109X(20)30127-3
  • Abdulah R, Insani WN, Destiani DP, et al. Polypharmacy leads to increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities. Ther Clin Risk Manag. 2018;14:1591–1597. doi:10.2147/TCRM.S170475
  • Yang M, Lu J, Hao Q, et al. Does residing in urban or rural areas affect the incidence of polypharmacy among older adults in western China? Arch Gerontol Geriatr. 2015;60(2):328–333. doi:10.1016/j.archger.2014.11.004
  • Gnjidic D, Tinetti M, Allore HG. Assessing medication burden and polypharmacy: finding the perfect measure. Expert Rev Clin Pharmacol. 2017;10(4):345–347. doi:10.1080/17512433.2017.1301206
  • Lai X, Zhu H, Huo X, et al. The current status and associated factors of medication compliance in the elderly undergoing polypharmacy. J Chin Nurs Manag. 2016;16(12):1638–1642.
  • Ulley J, Harrop D, Ali A, et al. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review. BMC Geriatr. 2019;19(1):15. doi:10.1186/s12877-019-1031-4
  • Hanlon JT, Zhao X, Naples JG, et al. Central nervous system medication burden and serious falls in older nursing home residents. J Am Geriatr Soc. 2017;65(6):1183–1189. doi:10.1111/jgs.14759
  • Mohammed MA, Moles RJ, Chen TF. Medication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open. 2016;6(2):e10035. doi:10.1136/bmjopen-2015-010035
  • van der Laan DM, Elders PJM, Boons CCLM, et al. The impact of cardiovascular medication use on patients’ daily lives: a cross-sectional study. Int J Clin Pharm. 2018;40(2):412–420. doi:10.1007/s11096-018-0601-4
  • Krska J, Morecroft CW, Rowe PH, et al. Measuring the impact of long-term medicines use from the patient perspective. Int J Clin Pharm. 2014;36(4):675–678. doi:10.1007/s11096-014-9970-5
  • Krska J, Katusiime B, Corlett S. Validation of an instrument to measure patients’ experiences of medicine use: the Living with Medicines Questionnaire. Patient Prefer Adherence. 2017;11:671–679.
  • Katusiime B, Corlett S, Krska J. Development and validation of a revised instrument to measure burden of long-term medicines use: the Living with Medicines Questionnaire version 3. Patient Relat Outcome Meas. 2018;9:155–168.
  • Krska J, Morecroft CW, Poole H, et al. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–1169. doi:10.1007/s11096-013-9841-5
  • Carter SR, Bulanadi MG, Katusiime B, et al. Comprehensibly measuring patients’ subjective thoughts, feelings and experiences of living with medicines: the Living with Medicines Questionnaire (LMQ). Int J Clin Pharm. 2015;37(2):424–425.
  • Wuyts J, Maesschalck J, De Wulf I, et al. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): patient-reported outcome measures. Res Social Adm Pharm. 2020.
  • Tordoff JM, Brenkley C, Krska J, et al. Exploring medicines burden among adults in New Zealand: a cross-sectional survey. Patient Prefer Adherence. 2019;13:2171–2184. doi:10.2147/PPA.S231202
  • Krska J, Corlett S, Katusiime B. Complexity of medicine regimens and patient perception of medicine burden. Pharmacy. 2019;7(1):18. doi:10.3390/pharmacy7010018
  • Zidan A, Awisu A, El-Hajj MS, et al. Medication-related burden among patients with chronic disease conditions: perspectives of patients attending non-communicable disease clinics in a primary healthcare setting in Qatar. Pharmacy. 2018;6(3):85. doi:10.3390/pharmacy6030085
  • Zidan A, Awaisu A, Hasan S, et al. The living with medicines questionnaire: translation and cultural adaptation into the Arabic context. Value Health Reg Issues. 2016;10:36–40. doi:10.1016/j.vhri.2016.07.001
  • Liu F, Liu YL, Chen Q, et al. Investigation of the affordability of chronic diseases drug use in families from three provinces in Western China. Chin J Health Policy. 2017;10(12):54–58.
  • Wei L, Champman S, Li X, et al. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China. BMJ Open. 2017;7(10):e17293. doi:10.1136/bmjopen-2017-017293
  • Chen LI. Communication of chinese from the perspective of language ecology. Jianghai Acad J. 2017;4:216–221.
  • Jones PS, Lee JW, Phillips LR, et al. An adaptation of Brislin’s translation model for cross-cultural research. Nurs Res. 2001;50(5):300–304. doi:10.1097/00006199-200109000-00008
  • Sousa VD, Rojjanasrirat W. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2011;17(2):268–274. doi:10.1111/j.1365-2753.2010.01434.x
  • Lynn MR. Determination and quantification of content validity. Nurs Res. 1986;35(6):382–385. doi:10.1097/00006199-198611000-00017
  • Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health. 2006;29(5):489–497. doi:10.1002/nur.20147
  • Shultz KS, Whitney DJ, Zickar MJ. Measurement Theory in Action: Case Studies and Exercises. New York: Routledge; 2013.
  • Wu ML. Questionnaire Statistical Analysis Practice: SPSS Operation and Applicatio. Chongqing: Chongqing University Press; 2019.
  • Ozer ZC, Firat MZ, Bektas HA. Confirmatory and exploratory factor analysis of the caregiver quality of life index-cancer with Turkish samples. Qual Life Res. 2009;18(7):913–921. doi:10.1007/s11136-009-9503-1
  • Barbaranelli C, Lee CS, Vellone E, et al. The problem with Cronbach’s Alpha: comment on Sijtsma and van der Ark (2015). Nurs Res. 2015;64(2):140–145. doi:10.1097/NNR.0000000000000079
  • Bentler PM. Alpha, dimension-free, and model-based internal consistency reliability. Psychometrika. 2009;74(1):137–143. doi:10.1007/s11336-008-9100-1
  • Bei L, Tianyue F, Yang Y. Discussion for the management model of  long-term medication of chronic disease under the influence of “Internet+”. CHINA HEALTH INSURANCE. 2020;7:57–60. doi:10.19546/j.issn.1674-3830.2020.7.012
  • Krska J, Katusiime B, Corlett SA. Patient experiences of the burden of using medicines for long-term conditions and factors affecting burden: a cross-sectional survey. Health Soc Care Community. 2018;26(6):946–959. doi:10.1111/hsc.12624